Scientists reveal new blood pressure treatment that works when others fail
Why it matters: Baxdrostat offers a new treatment for the 10-15% of hypertension patients whose blood pressure is uncontrolled by existing drugs.
- Baxdrostat is a new pill demonstrating strong results in lowering high blood pressure in patients unresponsive to standard treatments.
- Patients in a large global trial experienced a nearly 10 mmHg drop in blood pressure, a meaningful reduction.
- This reduction can significantly lower the risk of heart attacks and strokes, addressing a critical need for those with resistant hypertension.
A new drug, baxdrostat, is showing promising results in lowering dangerously high blood pressure in patients resistant to conventional treatments, achieving a nearly 10 mmHg reduction in a global trial. This significant drop could substantially decrease the risk of heart attacks and strokes for individuals with uncontrolled hypertension. The pill targets a specific hormone pathway, offering a novel approach where other medications have failed.
